Tags

Type your tag names separated by a space and hit enter

Peripheral vasodilators versus pentoxifylline for the treatment of intermittent claudication.
Ric Clin Lab. 1983; 13 Suppl 3:263-8.RC

Abstract

It should be recalled that the seven-center study conducted in the United States was initiated at a time when American physicians had recognized that past attempts to prove efficacy of peripheral vasodilators in treadmill testing had failed. The positive results derived from pentoxifylline treatment are significant because, for the first time, treadmill testing can prove the effectiveness of a hemorheologic drug, such as pentoxifylline, in the treatment of patients with intermittent claudication. Since treadmill testing is regarded as the most objective measurement of therapeutic success in claudicant patients, the positive results can assure us that hemorheologic drugs increasing erythrocyte flexibility are highly desired in treating peripheral vascular insufficiency, such as intermittent claudication.

Authors

No affiliation info available

Pub Type(s)

Comparative Study
Journal Article

Language

eng

PubMed ID

6143383

Citation

Aviado, D M.. "Peripheral Vasodilators Versus Pentoxifylline for the Treatment of Intermittent Claudication." La Ricerca in Clinica E in Laboratorio, vol. 13 Suppl 3, 1983, pp. 263-8.
Aviado DM. Peripheral vasodilators versus pentoxifylline for the treatment of intermittent claudication. Ric Clin Lab. 1983;13 Suppl 3:263-8.
Aviado, D. M. (1983). Peripheral vasodilators versus pentoxifylline for the treatment of intermittent claudication. La Ricerca in Clinica E in Laboratorio, 13 Suppl 3, 263-8.
Aviado DM. Peripheral Vasodilators Versus Pentoxifylline for the Treatment of Intermittent Claudication. Ric Clin Lab. 1983;13 Suppl 3:263-8. PubMed PMID: 6143383.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Peripheral vasodilators versus pentoxifylline for the treatment of intermittent claudication. A1 - Aviado,D M, PY - 1983/1/1/pubmed PY - 1983/1/1/medline PY - 1983/1/1/entrez SP - 263 EP - 8 JF - La Ricerca in clinica e in laboratorio JO - Ric Clin Lab VL - 13 Suppl 3 N2 - It should be recalled that the seven-center study conducted in the United States was initiated at a time when American physicians had recognized that past attempts to prove efficacy of peripheral vasodilators in treadmill testing had failed. The positive results derived from pentoxifylline treatment are significant because, for the first time, treadmill testing can prove the effectiveness of a hemorheologic drug, such as pentoxifylline, in the treatment of patients with intermittent claudication. Since treadmill testing is regarded as the most objective measurement of therapeutic success in claudicant patients, the positive results can assure us that hemorheologic drugs increasing erythrocyte flexibility are highly desired in treating peripheral vascular insufficiency, such as intermittent claudication. SN - 0390-5748 UR - https://www.unboundmedicine.com/medline/citation/6143383/Peripheral_vasodilators_versus_pentoxifylline_for_the_treatment_of_intermittent_claudication_ DB - PRIME DP - Unbound Medicine ER -